Apolipoprotein E, angiotensin-converting enzyme and α-1-antichymotrypsin genotypes are not associated with post-stroke dementia

被引:30
作者
Arpa, A
del Ser, T
Goda, G
Barba, R
Bornstein, B
机构
[1] Hosp Severo Ochoa, Serv Bioquim, Madrid 28911, Spain
[2] Hosp Severo Ochoa, Secc Neurol, Madrid, Spain
[3] Hosp Alcorcon, Med Interna Serv, Madrid, Spain
关键词
dementia; stroke; apolipoprotein E; angiotensin-converting enzyme; alpha-1-antichymotrypsin; polymorphisins; genotype;
D O I
10.1016/S0022-510X(03)00026-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There is evidence that indicates the involvement of environmental and genetic factors in the pathogenesis of post-stroke dementia (PSD). In the present work, we examined different polygenic influences on the risk of PSD in a series of stroke patients. We studied 150 consecutive patients evaluated 3 months after suffering acute strokes. All patients were evaluated with a prospective standard protocol and genotyped for vascular disease-associated polymorphisms in the genes coding for apolipoprotein E (including apoE coding and apoE promoter polymorphisms), angiotensin-converting enzyme (ACE) and alpha-l-antichymotrypsin (ACT). Thirty-two cases (21.3%) resulted in dementia 3 months after the stroke. In patients with PSD, the frequency of apoE epsilon4 (0.08), ACE-D (0.64), ACT-A (0.62) alleles and apoE gene promoter polymorphisms(-491/A,0.88; -427/C, 0.02) was similar to that of patients without PSD (apoE epsilon4: 0.10,p-0.79; ACE-D: 0.56, p-0.36; ACT-A:0.51, p=0.21; -491/A: 0.86, p=1.00; -427/C: 0.08,p=0.29). Our data indicate that PSD is not associated with the genetic risk factors of vascular dementia (VD) that were studied, and that additional factors may contribute to the pathogenesis of PSD. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:77 / 82
页数:6
相关论文
共 54 条
[1]   The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment [J].
Amouyel, P ;
Richard, F ;
Cottel, D ;
Amant, C ;
Codron, V ;
Helbecque, N .
NEUROSCIENCE LETTERS, 1996, 217 (2-3) :203-205
[2]   The renin angiotensin system and Alzheimer's disease [J].
Amouyel, P ;
Richard, F ;
Berr, C ;
David-Fromentin, I ;
Helbecque, N .
VASCULAR FACTORS IN ALZHEIMER'S DISEASE, 2000, 903 :437-441
[3]   Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene [J].
Artiga, MJ ;
Bullido, MJ ;
Frank, A ;
Sastre, I ;
Recuero, M ;
Garcia, MA ;
Lendon, CL ;
Han, SW ;
Morris, JC ;
Vázquez, J ;
Goate, A ;
Valdivieso, F .
HUMAN MOLECULAR GENETICS, 1998, 7 (12) :1887-1892
[4]   Poststroke dementia -: Clinical features and risk factors [J].
Barba, R ;
Martínez-Espinosa, S ;
Rodríguez-García, E ;
Pondal, M ;
Vivancos, J ;
Del Ser, T .
STROKE, 2000, 31 (07) :1494-1501
[5]   Apolipoprotein E ε4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias [J].
Barber, R ;
Gholkar, A ;
Scheltens, P ;
Ballard, C ;
McKeith, IG ;
Morris, CM ;
O'Brien, JT .
ARCHIVES OF NEUROLOGY, 1999, 56 (08) :961-965
[6]   Relationships between cholesterol, apolipoprotein E polymorphism and dementia: A cross-sectional analysis from the PAQUID study [J].
Bonarek, M ;
Barberger-Gateau, P ;
Letenneur, L ;
Deschamps, V ;
Iron, A ;
Dubroca, B ;
Dartigues, JF .
NEUROEPIDEMIOLOGY, 2000, 19 (03) :141-148
[7]   The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder [J].
Bouffard, R ;
Hechtman, L ;
Minde, K ;
Iaboni-Kassab, F .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2003, 48 (08) :546-554
[8]   A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia [J].
Bullido, MJ ;
Artiga, MJ ;
Recuero, M ;
Sastre, I ;
Garcia, MA ;
Aldudo, J ;
Lendon, C ;
Han, SW ;
Morris, JC ;
Frank, A ;
Vázquez, J ;
Goate, A ;
Valdivieso, F .
NATURE GENETICS, 1998, 18 (01) :69-71
[9]   DELETION POLYMORPHISM IN THE GENE FOR ANGIOTENSIN-CONVERTING ENZYME IS A POTENT RISK FACTOR FOR MYOCARDIAL-INFARCTION [J].
CAMBIEN, F ;
POIRIER, O ;
LECERF, L ;
EVANS, A ;
CAMBOU, JP ;
ARVEILER, D ;
LUC, G ;
BARD, JM ;
BARA, L ;
RICARD, S ;
TIRET, L ;
AMOUYEL, P ;
ALHENCGELAS, F ;
SOUBRIER, F .
NATURE, 1992, 359 (6396) :641-644
[10]   Angiotensin-converting enzyme insertion deletion polymorphism and cerebrovascular disease [J].
Catto, A ;
Carter, AM ;
Barrett, JH ;
Stickland, M ;
Bamford, J ;
Davies, JA ;
Grant, PJ .
STROKE, 1996, 27 (03) :435-440